Through PPARα-mediated regulation of inflammatory pathways and cellular metabolism, fenofibrate, PPARα agonist, exhibits combined neuroprotective and antidiabetic properties capable of ameliorating both Alzheimer’s disease pathology and type 2 diabetes complications [64]. This evidence concerns the gene PPARA and Alzheimer disease.